Aurora Spine reported a total revenue of $2.96 million in the first quarter of 2023, a 16.7 percent decrease compared to the same period in 2022.

Here are 35 spine and orthopedic medtech companies to follow in 2023.

Here are six spine devices garnering attention from the FDA that Becker's has reported on since May 4:

Centinel Spine in the first quarter of 2023 saw record worldwide motion preservation sales, the devicemaker said May 18.

CTL Amedica's Nitro interbody fusion cage system portfolio was cleared by the FDA, the devicemaker said May 18. 

Since its launch in 2008, Eminent Spine has evolved significantly— having started as a polyetheretherketone (PEEK) interbody spinal fusion devices company that shifted focus to pedicle screws and now specializes in 3D titanium printing technology.

Medical technology companies Surgalign and NuVasive posted their first quarter financial results for 2023. 

Medtronic and Stryker both have plans to lay off swaths of employees.

Abbott's spinal cord stimulation devices earned FDA approval to address chronic back pain for patients who aren't eligible for spine surgery, the medtech company said May 16.

Globus Medical recieved FDA aproval for its Reflect scoliosis correction system, the devicemaker said May 15.

Waypoint Orthopedics earned FDA approval for the Waypoint GPS, a bone awl for pedicle screw pilot hole drilling, the devicemaker said May 15.

Stryker plans to lay off more than 500 employees by the end of December as it closes its Lakeland, Fla. facility, according to a WARN notice.

Medical technology company Surgalign saw a $3.9 million dip in revenue in the first quarter of 2023 as compared with the same period last year, according to the company's first quarter financial report, released on May 11. 

NuVasive on May 10 posted first quarter sales of $307.7 million.

Orthofix on May 9 posted $175.2 million in first quarter revenue.

Intelivation Technologies' Golden Isles minimally invasive screw system was launched, the devicemaker said May 9.

Happe Spine's Integrate-C interbody fusion system earned FDA 510(k) clearance, the devicemaker said May 8.

Surgalign launched Holo AI Insights for neurovascular research, the medtech company said May 8.

Globus Medical's planned merger with NuVasive will likely close in the third quarter of 2023 instead of mid-year, CEO Dan Scavilla said in a May 4 first quarter earnings call.

Globus Medical on May 4 posted first quarter sales of $276.7 million.